Christopher P Sheehan

Title: Christopher P. Sheehan: Innovator in Biological Assays

Introduction

Christopher P. Sheehan is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of biological assays, particularly through his innovative methods for measuring ligands in biological fluids. His work has implications for various applications in medical and biological research.

Latest Patents

Christopher P. Sheehan holds a patent for a "Method for measuring the free fraction of ligands in biological fluids." This one-step assay allows for the determination of the free portion of a ligand in a biological sample. The method involves incubating a mixture of the sample with a labeled antibody for the ligand and a ligand analogue that competes for binding to the antibody. The assay is characterized by selecting a ligand analogue with a lower affinity for the antibody than the ligand itself. The preferred binding affinity for an insolubilized ligand analogue ranges from 0.01% to 10% of that of the ligand. Exemplified ligand/ligand analogue pairs include T4/T3 (Thyroxine/Tri-iodothyronine), Testosterone/etiocholanol, and T3/T2.

Career Highlights

Christopher is associated with Amersham International Plc, where he has contributed to advancements in biological research. His work has been instrumental in developing more efficient and accurate methods for measuring ligands, which are crucial for understanding various biological processes.

Collaborations

Throughout his career, Christopher has collaborated with esteemed colleagues, including John E. Midgley and Nicos D. Christofides. These collaborations have further enhanced the impact of his work in the field.

Conclusion

Christopher P. Sheehan's innovative approach to measuring ligands in biological fluids has paved the way for advancements in medical research. His contributions continue to influence the field, showcasing the importance of innovation in scientific discovery.